Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Tax Provisions: 2010-2018

Historic Tax Provisions for China Pharma Holdings (CPHI) over the last 9 years, with Dec 2018 value amounting to -$178,408.

  • China Pharma Holdings' Tax Provisions fell 317.85% to -$66,498 in Q4 2018 from the same period last year, while for Dec 2018 it was -$178,408, marking a year-over-year decrease of 245.48%. This contributed to the annual value of -$178,408 for FY2018, which is 245.48% down from last year.
  • Per China Pharma Holdings' latest filing, its Tax Provisions stood at -$178,408 for FY2018, which was down 245.48% from $122,631 recorded in FY2017.
  • China Pharma Holdings' Tax Provisions' 5-year high stood at $308,175 during FY2016, with a 5-year trough of -$178,408 in FY2018.
  • Its 3-year average for Tax Provisions is $84,133, with a median of $122,631 in 2017.
  • In the last 5 years, China Pharma Holdings' Tax Provisions spiked by 609.89% in 2016 and then tumbled by 245.48% in 2018.
  • China Pharma Holdings' Tax Provisions (Yearly) stood at -$77,042 in 2014, then rose by 21.55% to -$60,439 in 2015, then skyrocketed by 609.89% to $308,175 in 2016, then slumped by 60.21% to $122,631 in 2017, then plummeted by 245.48% to -$178,408 in 2018.